A detailed history of Global X Japan Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Global X Japan Co., Ltd. holds 2,394 shares of ABBV stock, worth $420,338. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,394
Previous 2,503 4.35%
Holding current value
$420,338
Previous $429 Million 10.12%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $17,858 - $21,726
-109 Reduced 4.35%
2,394 $473 Million
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $2,321 - $2,711
-15 Reduced 0.6%
2,503 $429 Million
Q1 2024

Jul 01, 2024

BUY
$159.82 - $182.1 $36,119 - $41,154
226 Added 9.86%
2,518 $459 Million
Q4 2023

Jul 01, 2024

BUY
$137.6 - $154.97 $315,379 - $355,191
2,292 New
2,292 $355 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Global X Japan Co., Ltd. Portfolio

Follow Global X Japan Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global X Japan Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Global X Japan Co., Ltd. with notifications on news.